1-9 of 9
Kentaro Yoshimatsu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1299: Potential antitumor effects of a Golgi disrupting agent, M-COPA, via targeting cell-extracellular matrix interaction under the spheroid culture conditions

Yoshimi Ohashi, Kazuma Takeuchi, Mutsumi Okamura, Akinobu Akatsuka, Isamu Shiina, Kentaro Yoshimatsu, Shingo Dan
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1299.
https://doi.org/10.1158/1538-7445.AM2019-1299
Published: 01 July 2019
View article titled, Abstract 1299: Potential antitumor effects of a Golgi disrupting agent, M-COPA, <em>via</em> targeting cell-extracellular matrix interaction under the spheroid culture conditions
Journal Articles

M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers

Yoshimi Ohashi, Mutsumi Okamura, Asaka Hirosawa, Naomi Tamaki, Akinobu Akatsuka, Kuo-Ming Wu, Hyeong-Wook Choi, Kentaro Yoshimatsu, Isamu Shiina, Takao Yamori, Shingo Dan
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (13): 3895–3903.
https://doi.org/10.1158/0008-5472.CAN-15-2220
Published: 30 June 2016
View article titled, M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
Open the PDF for M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers in another window
Includes: Supplementary data
Journal Articles

E7107, a new 7-urethane derivative of pladienolide D: Correlation of the profile of cell cycle regulatory molecules with tumor cells’ response

Toshimitsu Uenaka, Masao Iwata, Yoichi Ozawa, Hajime Shimizu, Yoshihiko Kotake, Yoshiharu Mizui, Kentaro Yoshimatsu, Makoto Asada
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 691.
Published: 01 April 2004
View article titled, E7107, a new 7-urethane derivative of pladienolide D: Correlation of the profile of cell cycle regulatory molecules with tumor cells’ response
Journal Articles

E7107, a new 7-urethane derivative of pladienolide D, displays curative effect against several human tumor xenografts

Masao Iwata, Yoichi Ozawa, Toshimitsu Uenaka, Hajime Shimizu, Jun Niijima, Regina M. Kanada, Yoshio Fukuda, Mitsuo Nagai, Yoshihiko Kotake, Masashi Yoshida, Toshio Tsuchida, Yoshiharu Mizui, Kentaro Yoshimatsu, Makoto Asada
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 691.
Published: 01 April 2004
View article titled, E7107, a new 7-urethane derivative of pladienolide D, displays curative effect against several human tumor xenografts
Journal Articles

E7107, a new 7-urethane derivative of pladienolide D: Discovery of a novel antitumor agent

Jun Niijima, Yoshihiko Kotake, Regina M. Kanada, Mitsuo Nagai, Yoshio Fukuda, Takashi Sakai, Hiroyuki Ishihara, Masashi Yoshida, Toshio Tsuchida, Masao Iwata, Toshimitsu Uenaka, Yoshiharu Mizui, Shinya Abe, Kentaro Yoshimatsu, Makoto Asada
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 691.
Published: 01 April 2004
View article titled, E7107, a new 7-urethane derivative of pladienolide D: Discovery of a novel antitumor agent
Journal Articles

Sulfonamide Derivative, E7820, Is a Unique Angiogenesis Inhibitor Suppressing an Expression of Integrin α2 Subunit on Endothelium

Yasuhiro Funahashi, Naoko Hata Sugi, Taro Semba, Yuji Yamamoto, Shinichi Hamaoka, Naoko Tsukahara-Tamai, Yoichi Ozawa, Akihiko Tsuruoka, Kazumasa Nara, Keiko Takahashi, Tadashi Okabe, Junichi Kamata, Takashi Owa, Norihiro Ueda, Toru Haneda, Masahiro Yonaga, Kentaro Yoshimatsu, Toshiaki Wakabayashi
Journal: Cancer Research
Cancer Res (2002) 62 (21): 6116–6123.
Published: 01 November 2002
View article titled, Sulfonamide Derivative, E7820, Is a Unique Angiogenesis Inhibitor Suppressing an Expression of Integrin α2 Subunit on Endothelium
Open the PDF for Sulfonamide Derivative, E7820, Is a Unique Angiogenesis Inhibitor Suppressing an Expression of Integrin α2 Subunit on Endothelium in another window
Journal Articles

In Vitro and In Vivo Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B

Murray J. Towle, Kathleen A. Salvato, Jacqueline Budrow, Bruce F. Wels, Galina Kuznetsov, Kimberley K. Aalfs, Susan Welsh, Wanjun Zheng, Boris M. Seletsky, Monica H. Palme, Gregory J. Habgood, Lori A. Singer, Lucian V. DiPietro, Yuan Wang, Jack J. Chen, David A. Quincy, Ashley Davis, Kentaro Yoshimatsu, Yoshito Kishi, Melvin J. Yu, Bruce A. Littlefield
Journal: Cancer Research
Cancer Res (2001) 61 (3): 1013–1021.
Published: 02 February 2001
View article titled, <em>In Vitro</em> and <em>In Vivo</em> Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B
Open the PDF for <em>In Vitro</em> and <em>In Vivo</em> Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B in another window
Journal Articles

Mechanism of Action of E7010, an Orally Active Sulfonamide Antitumor Agent: Inhibition of Mitosis by Binding to the Colchicine Site of Tubulin

Kentaro Yoshimatsu, Atsumi Yamaguchi, Hiroshi Yoshino, Nozomu Koyanagi, Kyosuke Kitoh
Journal: Cancer Research
Cancer Res (1997) 57 (15): 3208–3213.
Published: 01 August 1997
View article titled, Mechanism of Action of E7010, an Orally Active Sulfonamide Antitumor Agent: Inhibition of Mitosis by Binding to the Colchicine Site of Tubulin
Open the PDF for Mechanism of Action of E7010, an Orally Active Sulfonamide Antitumor Agent: Inhibition of Mitosis by Binding to the Colchicine Site of Tubulin in another window
Journal Articles

Inhibition of Human Tumor Xenograft Growth by Treatment with the Farnesyl Transferase Inhibitor B956

Takeshi Nagasu, Kentaro Yoshimatsu, Cheryl Rowell, Michael D. Lewis, Ana Maria Garcia
Journal: Cancer Research
Cancer Res (1995) 55 (22): 5310–5314.
Published: 01 November 1995
View article titled, Inhibition of Human Tumor Xenograft Growth by Treatment with the Farnesyl Transferase Inhibitor B956
Open the PDF for Inhibition of Human Tumor Xenograft Growth by Treatment with the Farnesyl Transferase Inhibitor B956 in another window